News

Etihad Cargo, the cargo and logistics arm of Etihad Airways, achieved year-on-year growth of the carrier's dedicated cool chain products — PharmaLife and FreshForward — in 2023. The airline recorded the highest volumes of pharmaceuticals transported in Etihad Cargo's...

WuXi Advanced Therapies , a wholly owned subsidiary of WuXi AppTec announced that the U.S. FDA has approved its Philadelphia site to begin the analytical testing and manufacturing of AMTAGVI for Iovance, which received FDA accelerated approval of its...

The Defense Threat Reduction Agency's (DTRA) Joint Science and Technology Office (JSTO) for the Chemical and Biological Defense (CBD) Program has awarded, through the Medical CBRN Defense Consortium (MCDC) requirement 22-05, "Adjuvant Activity to Vaccines Prototype," a 5-year...

There are currently more than 3,000 advanced therapies in the development pipeline globally, along with 124 approved therapies. To enable this innovation and transformation of therapeutic options, Azzur Group today announces the introduction of analytical laboratory testing services for...

AstraZeneca announced the successful completion of the acquisition of Gracell Biotechnologies Inc , a global clinical-stage biopharmaceutical company developing innovative cell therapies for the treatment of cancer and autoimmune diseases, furthering AstraZeneca’s cell therapy ambition. The acquisition enriches AstraZeneca’s growing...

Viatris Inc. a global healthcare company, announced that its Aurangabad, India, facility has received certification from the British Standards Institution (BSI) for meeting a new industry standard on Minimized Risk of Antimicrobial Resistance (AMR). The standard was facilitated by BSI...

A team led by University College Dublin (UCD) has been working on an innovative research initiative that could transform pre-eclampsia diagnosis. It is designed to support clinicians to make effective and efficient clinical diagnosis of suspected pre-eclampsia through intelligent...